Our Latest Stories

Our Science
July 24, 2025
Genomic Medicine Unit: Overcoming Gene Therapy’s Greatest Challenges

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.
Our Pipeline
5
Therapeutic areas
86
Compounds in clinical development
24
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
July 31, 2025
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
July 30, 2025
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
July 25, 2025
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
July 22, 2025
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline